Effects of Lavender and Rosemary Essential Oils on Sleep Quality and Mental Well-Being in Coronary Artery Disease Patients

Healing Aromas: The Effects of Lavender and Rosemary Essential Oils on Sleep Quality and Mental Well-Being in Coronary Artery Disease Patients: a Parallel Arm, Randomized, Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230702058649N1

Enrollment

148

Registered

2024-02-10

Start date

2024-02-20

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery disease. Ischaemic heart diseases

Interventions

Intervention 1: First intervention group: Aromatherapy with lavender, samples will be exposed to the aromatic substance three times a day at 8 am, 3 pm and 10 pm for 20 minutes by pouring 4 drops of t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Being diagnosed with coronary artery Disease Having no history of neuropsychiatric disease by self report Having no history of taking psychiatric medications Normal olfactory function Not using benzodiazepines, sedatives and narcotics No history of asthma No history of allergies to plants or any seasonal allergies Absence of severe pain causes sleep disturbance Obtaining scores of greater than five from the PSQI Sleep quality questionnaire Having an ejection fraction above 45% Being able to read and write Access to social media

Exclusion criteria

Exclusion criteria: Acute pain at the time of completing the questionnaire Any case that causes olfactory disorders during study Showing an allergic reaction to the smell of essential oils Showing discomfort with the smell of essential oils Occurrence of life-threatening complications such as cardiopulmonary resuscitation

Design outcomes

Primary

Measure	Time frame
Depression score in Cardiac Depression Scale (CDS). Timepoint: Before the intervention, 14 and 30 days after the start of the intervention. Method of measurement: Cardiac Depression Scale (CDS).;Anxiety score in Hospital Anxiety and Depression Scale (HADS ). Timepoint: Before the intervention, 14 and 30 days after the start of the intervention. Method of measurement: Hospital Anxiety and Depression Scale (HADS ).;Sleep quality score in Pittsburgh Sleep Quality Index (PSQI). Timepoint: Before the intervention, 14 and 30 days after the start of the intervention. Method of measurement: Pittsburgh Sleep Quality Index (PSQI).	—

Measure

Time frame

Depression score in Cardiac Depression Scale (CDS). Timepoint: Before the intervention, 14 and 30 days after the start of the intervention. Method of measurement: Cardiac Depression Scale (CDS).;Anxiety score in Hospital Anxiety and Depression Scale (HADS ). Timepoint: Before the intervention, 14 and 30 days after the start of the intervention. Method of measurement: Hospital Anxiety and Depression Scale (HADS ).;Sleep quality score in Pittsburgh Sleep Quality Index (PSQI). Timepoint: Before the intervention, 14 and 30 days after the start of the intervention. Method of measurement: Pittsburgh Sleep Quality Index (PSQI).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Ahmadjani

Mazandaran University of Medical Sciences

Fateme.Ahmadjanii@gmail.com+98 11 3223 1149

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026